Cargando…
Interleukin-15 in Outcomes of Pregnancy
Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human s...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541205/ https://www.ncbi.nlm.nih.gov/pubmed/34681751 http://dx.doi.org/10.3390/ijms222011094 |
_version_ | 1784589173326348288 |
---|---|
author | Gordon, Scott M. |
author_facet | Gordon, Scott M. |
author_sort | Gordon, Scott M. |
collection | PubMed |
description | Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human studies suggest that homeostasis of IL-15 is essential for healthy pregnancy. Dysregulation of IL-15 is associated with adverse outcomes of pregnancy. Herein, we review producers of IL-15 and responders to IL-15, including non-traditional responders in the maternal uterus and fetal placenta. We also review regulation of IL-15 at the maternal–fetal interface and propose mechanisms of action of IL-15 to facilitate additional study of this critical cytokine in the context of pregnancy. |
format | Online Article Text |
id | pubmed-8541205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85412052021-10-24 Interleukin-15 in Outcomes of Pregnancy Gordon, Scott M. Int J Mol Sci Review Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human studies suggest that homeostasis of IL-15 is essential for healthy pregnancy. Dysregulation of IL-15 is associated with adverse outcomes of pregnancy. Herein, we review producers of IL-15 and responders to IL-15, including non-traditional responders in the maternal uterus and fetal placenta. We also review regulation of IL-15 at the maternal–fetal interface and propose mechanisms of action of IL-15 to facilitate additional study of this critical cytokine in the context of pregnancy. MDPI 2021-10-14 /pmc/articles/PMC8541205/ /pubmed/34681751 http://dx.doi.org/10.3390/ijms222011094 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gordon, Scott M. Interleukin-15 in Outcomes of Pregnancy |
title | Interleukin-15 in Outcomes of Pregnancy |
title_full | Interleukin-15 in Outcomes of Pregnancy |
title_fullStr | Interleukin-15 in Outcomes of Pregnancy |
title_full_unstemmed | Interleukin-15 in Outcomes of Pregnancy |
title_short | Interleukin-15 in Outcomes of Pregnancy |
title_sort | interleukin-15 in outcomes of pregnancy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541205/ https://www.ncbi.nlm.nih.gov/pubmed/34681751 http://dx.doi.org/10.3390/ijms222011094 |
work_keys_str_mv | AT gordonscottm interleukin15inoutcomesofpregnancy |